Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
9088-6 Sodium intake SRat ^Patient 1H Qn     ACTIVE Sodium intake 1 hour   MIN DefinitionDescription     mol/h             IO_IN_SALTS+CALS   9088-6                 0 Sodium intake 1h           1 hour; 1.0Hr; 1HR; 60 min; 60 minutes; 60M; 60min; IO_INTAKE_SALTS+CALORIES; Na; Na+; QNT; Quan; Quant; Quantitative; Salt intake; sRate; Substance Rate; Table salt 2.48 1.0i               mol/h       0
90880-6 Arachis hypogaea recombinant (rAra h) 6 Ab.IgE ACnc Ser Pt Qn     ACTIVE Peanut recombinant (rAra h) 6 IgE Ab [Units/volume] in Serum   MIN DefinitionDescription     kIU/mL             ALLERGY   90880-6         Both       0 Peanut (rAra h) 6 IgE Qn           ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f013; f13; f447; Immune globulin E; Immunoglobulin E; NR1B1; Peanut; Peanut (rAra h) 6; Point in time; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; Serum; SR 2.73 2.65               k[IU]/mL       0
90881-4 (Alternaria tenuis+Artemisia vulgaris+Betula verrucosa+Cladosporium herbarum+Phleum pratense) Ab.IgE PrThr Ser Pt Ord Multidisk   ACTIVE Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab [Presence] in Serum by Multidisk   ADD DefinitionDescription                   ALLERGY   90881-4   Multidisk     Both       0 Inhalant Allerg Mix 6 IgE Ql           3gAllergy IP6; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C herbarum; Common silver birch; g006; g6; Hormodendrum; IFR; Immune globulin E; Immunoglobulin E; Inhalant Allerg Mix 6; IP6; Isoflavone reductase; m002; m2; Mugwort; Ordinal; Phleum pretense; Point in time; PR; QL; Qual; Qualitative; Random; rx6; Screen; Serum; Siemens IP6; Silver Birch; SR; t3; Timothy; Timothy grass; w006; w6 2.65 2.65                       0
90882-2 Staphylococcus aureus enterotoxin E Ab.IgE.RAST class PrThr Ser Pt Ord     DEPRECATED Deprecated Staphylococcus aureus enterotoxin E IgE Ab RAST class [Presence] in Serum   DEL DefinitionDescription                   ALLERGY   90882-2         Both       0 Deprecated S aureus Etx E IgE RAST Ql           ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Etx; IgE RAST; Immune globulin E; Immunoglobulin E; o71; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rh Blood Group System; Rm225; S aureus; S aureus Etx; S aureus Etx E; Screen; Serum; SR; Staph; Staphylococcal enterotoxin 2.75 2.65       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
90883-0 PROMIS pediatric item bank - mobility - version 2.0 - ^Patient Pt - PROMIS.PEDS   ACTIVE PROMIS pediatric item bank - mobility - version 2.0   ADD DefinitionDescription         Copyright Ã?© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx         PANEL.SURVEY.PROMIS   90883-0   PROMIS.PEDS     Order       0             Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS 2.65 2.65   Panel     Copyright Ã?© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx             0
90884-8 PROMIS pediatric mobility - version 2.0 T-Score Tscore ^Patient Pt Qn PROMIS.PEDS   ACTIVE PROMIS pediatric mobility - version 2.0 T-score   ADD DefinitionDescription     Tscore   Copyright Ã?© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx         SURVEY.PROMIS   90884-8   PROMIS.PEDS     Observation       0             Patient Reported Outcomes Information System; PEDS; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score 2.65 2.65         Copyright Ã?© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx     {Tscore}       0
90885-5 Influenza virus D RNA ThreshNum XXX Pt Qn Probe.amp.tar   ACTIVE Influenza virus D RNA [Cycle Threshold #] in Specimen by NAA with probe detection   MIN DefinitionDescription     Ct             MICRO   90885-5   Probe.amp.tar     Both       0 FLUDV RNA Ct Spec Qn NAA+probe           3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Dextro; DNA NUCLEIC ACID PROBE; DNA probe; FLUDV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary 2.69 2.65               {Ct_value}       0
90886-3 Influenza virus B RNA ThreshNum XXX Pt Qn Probe.amp.tar   ACTIVE Influenza virus B RNA [Cycle Threshold #] in Specimen by NAA with probe detection   MIN DefinitionDescription     Ct             MICRO   90886-3   Probe.amp.tar     Both       0 FLUBV RNA Ct Spec Qn NAA+probe           3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified 2.69 2.65               {Ct_value}       0
90887-1 Porcine circovirus type 3 ORF2 gene Seq Isolate Pt Nom Sequencing   ACTIVE Porcine circovirus type 3 ORF2 gene [Nucleotide sequence] in Isolate by Sequencing   ADD DefinitionDescription                   MICRO   90887-1   Sequencing     Both       0 PCV 3 ORF2 gene Islt-Seq           Circo virus; high-throughput sequencing; HTS; ID; III; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; PCV; PCV 3 ORF2 gene; PCV3; Point in time; Pork; Random; Swine; Vet; Veterinary 2.65 2.65                       0
90888-9 Porcine circovirus type 3 DNA NCnc XXX Pt Qn Probe.amp.tar   ACTIVE Porcine circovirus type 3 DNA [#/volume] (viral load) in Specimen by NAA with probe detection   MIN DefinitionDescription     copies/mL             MICRO   90888-9   Probe.amp.tar     Both       0 PCV3 DNA # Spec NAA+probe           #; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Circo virus; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; PCV; PCV3; PCV3 DNA; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral load 2.69 2.65               {copies}/mL       0
90889-7 Porcine circovirus type 2 Ab.IgG Titr XXX Pt SemiQn IF   ACTIVE Porcine circovirus type 2 IgG Ab [Titer] in Specimen by Immunofluorescence   MAJ DefinitionDescription     titer             MICRO   90889-7   IF     Both       0 PCV2 IgG Titr Spec IF           ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Circo virus; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; II; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Other; PCV; PCV2; PCV2 Ab; PCV2 IgG; Point in time; Pork; Random; SmQn; Spec; Swine; Time Resolved Fluorescence; Titer; Titered; Titre; To be specified in another part of the message; TRF; Ttr; Unspecified; Vet; Veterinary 2.75 2.65               {titer}       0
9089-4 Sodium intake SRat ^Patient 8H Qn     ACTIVE Sodium intake 8 hour   MIN DefinitionDescription     mol/8 H             IO_IN_SALTS+CALS   9089-4                 0 Sodium intake 8h           1/3 day; 8 hours; 8HR; IO_INTAKE_SALTS+CALORIES; Na; Na+; QNT; Quan; Quant; Quantitative; Salt intake; sRate; Substance Rate; Table salt 2.48 1.0i               mol/(8.h)       0
90890-5 Benzodiazepines panel - Urine Pt - Confirm   ACTIVE Benzodiazepines panel - Urine by Confirmatory method   ADD DefinitionDescription                   PANEL.DRUG/TOX   90890-5   Confirm     Order       0 Benzodiazepines Pnl Ur Cfm           Benz; Benzodiaz; Benzodiazepine; Benzodiazepines Pnl; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn 2.65 2.65   Panel                   0
90891-3 Estradiol^2H post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Estradiol (E2) [Mass/volume] in Serum or Plasma --2 hours post XXX challenge   ADD DefinitionDescription     pg/mL             CHAL   90891-3         Observation       0 Estradiol 2h p chal SerPl-mCnc           120 min; 120 minutes; 120min; 17-beta estradiol; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; E2; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.65 2.65               pg/mL       0
90892-1 Borrelia sp panel - Bld Pt - Non-probe.amp.tar   ACTIVE Borrelia sp panel - Blood by NAA with non-probe detection   PANEL DefinitionDescription                   PANEL.MICRO   90892-1   Non-probe.amp.tar     Order       0 B sp panel Bld NAA+non-probe           3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B sp panel; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyme; Lyme disease; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Relapsing fever; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood 2.68 2.65   Panel                   0
90893-9 Borrelia burgdorferi bba64 gene PrThr Bld Pt Ord Non-probe.amp.tar   ACTIVE Borrelia burgdorferi bba64 gene [Presence] in Blood by NAA with non-probe detection   ADD DefinitionDescription                   MICRO   90893-9   Non-probe.amp.tar     Both       0 B burg bba64 gene Bld Ql NAA+non-probe           3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B burg; B burg bba64 gene; B burgdor; B burgdorferi; Bb; Blood; Burgdorf; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyme; Lyme disease; Lymes; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood 2.65 2.65                       0
90894-7 Noroxymorphone MCnc Urine Pt Qn Confirm   ACTIVE Noroxymorphone [Mass/volume] in Urine by Confirmatory method   ADD DefinitionDescription     ng/mL             DRUG/TOX   90894-7   Confirm     Both       0 Noroxymorphone Ur Cfm-mCnc           Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Oxycodone metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.65 2.65               ng/mL       0
90895-4 Task identifier ID ^Event Pt Nom     ACTIVE Task identifier   MIN DefinitionDescription                   ADMIN.ID   90895-4         Observation       0 Task ID           ADMIN; Ident; Identifier; Intradermal; Nominal; Point in time; Random 2.68 2.65                       0
90896-2 Person assigned to task Pn Personnel Pt Nom     ACTIVE Personnel Person assigned to task   MIN DefinitionDescription                   ADMIN   90896-2         Observation       0 Personnel Person assigned to task           ADMIN; Nominal; Person name; Persons; Point in time; Random 2.68 2.65                       0
90897-0 Percent of task completed NFr ^Event Pt Qn     ACTIVE Percent of task completed   MIN DefinitionDescription     %             ADMIN   90897-0         Observation       0 Percent of task completed NFr           ADMIN; Assignment; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random 2.68 2.65               %     Correct System since the percent task completed pertains to an event. 0
90898-8 HIV 1 proviral DNA reverse transcriptase & protease & integrase gene Seq Bld MC Pt Nom Sequencing   ACTIVE HIV 1 proviral DNA reverse transcriptase and protease and integrase gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing   ADD DefinitionDescription                   MICRO   90898-8   Sequencing     Both       0 HIV1 proviral DNA RT+PR+IN Bld MC-Seq           AIDS; Blood; Deoxyribonucleic acid; high-throughput sequencing; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; HIV1 proviral DNA RT + PR + IN; HTS; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Next generation sequencing; NGS; Nominal; PBMC; Peripheral blood mononuclear cells; Point in time; PR; Random; REV; RT; WB; Whole blood 2.65 2.65                       0
90899-6 HIV 1 proviral DNA reverse transcriptase & protease gene Seq Bld MC Pt Nom Sequencing   ACTIVE HIV 1 proviral DNA reverse transcriptase and protease gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing   ADD DefinitionDescription                   MICRO   90899-6   Sequencing     Both       0 HIV1 proviral DNA RT + PR Bld MC-Seq           AIDS; Blood; Deoxyribonucleic acid; high-throughput sequencing; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; HIV1 proviral DNA RT + PR; HTS; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Next generation sequencing; NGS; Nominal; PBMC; Peripheral blood mononuclear cells; Point in time; PR; Random; REV; RT; WB; Whole blood 2.65 2.65                       0
909-2 Ax Ab PrThr Ser/Plas^Donor Pt Ord     ACTIVE Ax Ab [Presence] in Serum or Plasma from Donor   MAJ DefinitionDescription                   BLDBK   909-2         Observation       0 Ax Ab SerPl Donr Ql           ABS; Aby; Antby; Anti; Antibodies; Antibody; Ao; Autoantibodies; Autoantibody; BLOOD BANK; Donr; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.56 1                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
9090-2 Sodium intake SRat ^Patient 10H Qn     ACTIVE Sodium intake 10 hour   MIN DefinitionDescription     mol/10 H             IO_IN_SALTS+CALS   9090-2                 0 Sodium intake 10h           10 hours; 10HR; IO_INTAKE_SALTS+CALORIES; Na; Na+; QNT; Quan; Quant; Quantitative; Salt intake; sRate; Substance Rate; Table salt 2.48 1.0i               mol/(10.h)       0
90900-2 HIV 1 proviral DNA integrase gene Seq Bld MC Pt Nom Sequencing   ACTIVE HIV 1 proviral DNA integrase gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing   ADD DefinitionDescription                   MICRO   90900-2   Sequencing     Both       0 HIV1 proviral DNA IN Bld MC-Seq           AIDS; Blood; Deoxyribonucleic acid; high-throughput sequencing; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; HIV1 proviral DNA IN; HTS; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Next generation sequencing; NGS; Nominal; PBMC; Peripheral blood mononuclear cells; Point in time; Random; WB; Whole blood 2.65 2.65                       0
104,672 results found